Related Experiment Video
Updated: Oct 10, 2025

Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics
Published on: May 11, 2016
Loss of TACC1 variant25 inducing cell proliferation and suppressing autophagy in head and neck squamous carcinoma
Pan Xu1,2,3,4,5, Ran Zhao1,2,3,4,5, Chen-Yang Zhang1
1Department of Oral Mucosal Diseases, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Abstract:
Transforming acidic coiled-coil containing protein1 (TACC1) is closely related to transcription, translation and centrosome dynamics. Dysregulation of TACC1 is associated with multiple malignancies. Alternative splicing (AS) of TACC1 produces multiple variants, which are of great significance in cancer biology. However, the expression and biological functions of TACC1 variants in head and neck squamous cell carcinoma (HNSCC) remain unclear. In this study, we found for the first time that TACC1 variants exhibited a characteristic expression pattern and that TACC1 variant25 (TACC1v25) was downregulated in HNSCC tissues and cell lines. Overexpression of TACC1v25 in Cal27 and Fadu cells significantly inhibited proliferation and promoted autophagy. Moreover, expression levels of nuclear pERK and p-mTOR were significantly decreased, while the expression of Beclin-1 and the LC3II/LC3I ratio were increased in TACC1v25-overexpressed Cal27 and Fadu cells. After the addition of AKT activator SC79 to TACC1v25-overexpressed Cal27 and Fadu cells, the autophagy levels were remarkably rescued. In conclusion, TACC1v25 inhibits HNSCC progression through the ERK and AKT/mTOR pathways by inhibiting proliferation and increasing autophagy. TACC1v25 might have potential use as a tumour suppressor in HNSCC.
Insights
Transforming acidic coiled-coil containing protein1 variant25 (TACC1v25) is downregulated in head and neck squamous cell carcinoma. TACC1v25 inhibits cancer progression by reducing proliferation and increasing autophagy via the ERK and AKT/mTOR pathways.
Area of Science:
- Molecular oncology
- Cellular biology
- Cancer research
Background:
- Transforming acidic coiled-coil containing protein1 (TACC1) plays roles in transcription, translation, and centrosome dynamics.
- TACC1 dysregulation is linked to various cancers, with alternative splicing producing significant variants.
- The specific roles of TACC1 variants in head and neck squamous cell carcinoma (HNSCC) are not well understood.
Purpose of the Study:
- To investigate the expression patterns and biological functions of TACC1 variants in HNSCC.
- To determine the specific role of TACC1 variant25 (TACC1v25) in HNSCC progression.
- To elucidate the molecular mechanisms underlying TACC1v25's effects in HNSCC.
Main Methods:
- Analysis of TACC1 variant expression in HNSCC tissues and cell lines.
- Overexpression of TACC1v25 in HNSCC cell lines (Cal27 and Fadu).
- Assessment of cell proliferation, autophagy markers (Beclin-1, LC3II/LC3I ratio), and signaling pathways (pERK, p-mTOR, AKT).
Main Results:
- TACC1 variants show a distinct expression pattern in HNSCC.
- TACC1v25 is significantly downregulated in HNSCC tissues and cell lines.
- Overexpression of TACC1v25 suppressed proliferation and enhanced autophagy in HNSCC cells.
- TACC1v25 overexpression led to decreased nuclear pERK and p-mTOR, and increased Beclin-1 and LC3II/LC3I ratio.
- Autophagy was rescued by activating the AKT pathway with SC79.
Conclusions:
- TACC1v25 inhibits HNSCC progression by reducing proliferation and promoting autophagy.
- The tumor-suppressive effects of TACC1v25 are mediated through the ERK and AKT/mTOR signaling pathways.
- TACC1v25 demonstrates potential as a therapeutic target or tumor suppressor in HNSCC.
Related Concept Videos
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Replicative Cell Senescence

